UCB Clinical Trial Call Center
+1 877 8229493 (UCB) · +1 877 822 9493 (UCB) · UCB Pharma
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name UCB Clinical Trial Call Center as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:48 UTC. Showing 200 of 270. Open this list on ClinicalTrials.gov
- Ph1NCT02529956 · A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With PsoriasisUCB Celltech · completed · Mild to Moderate Psoriasis · study director
- Ph1NCT02365948 · A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese SubjectsUCB Pharma SA · completed · Healthy Subjects · study director
- Ph1NCT02306629 · Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the BloodUCB Biopharma S.P.R.L. · completed · Systemic Lupus Erythematosus · study director
- Ph1NCT02230904 · A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's DiseaseUCB BIOSCIENCES GmbH · completed · Parkinson's Disease · study director
- N/ANCT02227355 · Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's DiseaseUCB Biopharma S.P.R.L. · completed · Idiopathic Parkinson's Disease · study director
- Ph1NCT02220153 · A First-In-Human Study With a Single Dose UCB7665 in Healthy VolunteersUCB Celltech · completed · Healthy · study director
- Ph1NCT02207595 · Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy SubjectsUCB Celltech · completed · Healthy Volunteers · study director
- Ph3NCT02192814 · Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset SeizuresUCB Japan Co. Ltd. · completed · Epilepsy, Partial-onset Seizures · study director
- Ph1NCT02141763 · Multiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisUCB Celltech · completed · Psoriatic Arthritis · study director
- Ph1NCT02101710 · Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male SubjectsUCB Korea Co., Ltd. · completed · Healthy · study director
- Ph2NCT02088957 · Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic SeizuresUCB BIOSCIENCES, Inc. · terminated · Nonconvulsive Electrographic Seizures · study director
- Ph1NCT02070796 · Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different FormulationsUCB Pharma SA · completed · Healthy · study director
- Ph1NCT01986608 · Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese SubjectsUCB Pharma SA · completed · Healthy Volunteers · study director
- Ph3NCT01954121 · Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset SeizuresUCB Pharma SA · completed · Epilepsy, Partial Seizures · study director
- Ph4NCT01883011 · A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery StrokeUCB S.A. - Pharma Sector · terminated · Acute Ischaemic Middle Cerebral Artery Stroke · study director
- Ph1NCT01854216 · Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian SubjectsUCB BIOSCIENCES GmbH · completed · Healthy · study director
- Ph1NCT01796899 · Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy VolunteersUCB Pharma SA · completed · Healthy Volunteers · study director
- Ph1NCT01796938 · Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy SubjectsUCB BIOSCIENCES GmbH · completed · Healthy, Renal Impairment · study director
- Ph4NCT01782222 · Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And ApathyUCB BIOSCIENCES GmbH · completed · Idiopathic Parkinson's Disease · study director
- Ph1NCT01764594 · Safety Study of CDP7657 in Patients With Systemic Lupus ErythematosusUCB Pharma · completed · Immune System Diseases, Autoimmune Diseases, Lupus Erythematosus, Systemic · study director
- Ph1NCT01761526 · Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female SubjectsUCB BIOSCIENCES GmbH · completed · Healthy · study director
- Ph4NCT01744496 · Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainUCB BIOSCIENCES GmbH · completed · Advanced Idiopathic Parkinson's Disease · study director
- Ph3NCT01723904 · A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's DiseaseUCB BIOSCIENCES GmbH · completed · Advanced Parkinson's Disease · study director
- Ph4NCT01711866 · A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's DiseaseUCB BIOSCIENCES GmbH · completed · Advanced Idiopathic Parkinson's Disease · study director
- Ph3NCT01710657 · A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset SeizuresUCB Pharma SA · completed · Epilepsy, Partial Onset Seizures · study director
- Ph1NCT01710670 · A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male SubjectsUCB Pharma SA · completed · Healthy Volunteers · study director
- N/ANCT01673282 · Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination TherapyUCB Pharma GmbH · completed · Focal Epilepsy With and Without Secondary Generalization · study director
- Ph3NCT01653262 · Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)UCB Pharma SA · completed · Epilepsy · study director
- Ph3NCT01646255 · Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease PatientsUCB Pharma · completed · Idiopathic Parkinson's Disease · study director
- Ph3NCT01646268 · Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease PatientsUCB Pharma · completed · IDIOPATHIC PARKINSON'S DISEASE · study director
- Ph2NCT01635621 · A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's DiseaseUCB BIOSCIENCES GmbH · withdrawn · Crohn's Disease · study director
- Ph1NCT01618903 · An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in ChineseUCB Pharma · completed · Human Volunteers · study director
- Ph1NCT01618877 · A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy VolunteersUCB Pharma · completed · Human Volunteers · study director
- N/ANCT01606670 · Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s DiseaseUCB Pharma GmbH · completed · Idiopathic Parkinson's Disease · study director
- N/ANCT01577264 · Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)UCB Pharma · terminated · Rheumatoid Arthritis, Crohn's Disease · study director
- Ph3NCT01569464 · Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)UCB Pharma · completed · Restless Legs Syndrome · study director
- Ph1NCT01565018 · Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese SubjectsUCB Pharma · completed · Healthy Volunteers · study director
- Ph3NCT01537042 · A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring HemodialysisUCB BIOSCIENCES GmbH · completed · Restless Legs Syndrome, End-Stage Renal Disease · study director
- Ph3NCT01536015 · Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal DysfunctionUCB Pharma · terminated · Advanced Parkinson's Disease · study director
- Ph2NCT01534403 · Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) SubjectsUCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph1NCT01530022 · Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy SubjectsUCB Pharma · completed · Healthy · study director
- Ph1NCT01530386 · A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy SubjectsUCB Pharma · completed · Healthy Subjects · study director
- N/ANCT01526434 · Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab PegolUCB Pharma SA · completed · Rheumatoid Arthritis · study director
- Ph1NCT01526083 · Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy MalesUCB Pharma · completed · Healthy Volunteers · study director
- Ph4NCT01523301 · Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease PatientsUCB Korea Co., Ltd. · completed · Idiopathic Parkinson's Disease · study director
- Ph3NCT01521923 · A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph4NCT01519882 · Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's DiseaseUCB Pharma SA · terminated · Advanced Idiopathic Parkinson's Disease · study director
- Ph3NCT01519791 · A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisUCB Pharma SA · completed · Rheumatoid Arthritis · study director
- Ph3NCT01506882 · An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal EpilepsyUCB Japan Co. Ltd. · completed · Epilepsy, Partial Onset Seizures · study director
- N/ANCT01504529 · Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With RotigotineUCB Pharma · completed · Parkinson's Disease · study director
- Ph4NCT01498822 · Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyKorea UCB Co., Ltd. · completed · Epilepsy · study director
- Ph2NCT01498120 · Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs SyndromeUCB BIOSCIENCES, Inc. · completed · Restless Legs Syndrome · study director
- Ph2NCT01495793 · Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs SyndromeUCB BIOSCIENCES, Inc. · completed · Restless Legs Syndrome · study director
- Ph4NCT01491113 · Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired PatientsUCB Pharma · completed · Healthy Subjects, Renal Impairments · study director
- Ph3NCT01484977 · eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetamUCB Pharma · completed · Epilepsy · study director
- Ph2NCT01463059 · Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) TherapyUCB Japan Co. Ltd. · completed · Rheumatoid Arthritis · study director
- Ph4NCT01455012 · Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs SyndromeUCB BIOSCIENCES GmbH · completed · Restless Legs Syndrome · study director
- Ph1NCT01450111 · To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean SubjectsUCB Pharma · completed · Epilepsy · study director
- Ph1/Ph2NCT01449071 · Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)UCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph4NCT01443364 · Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisUCB Italy s.p.a. · completed · Rheumatoid Arthritis · study director
- Ph3NCT01425463 · A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia SubjectsSanol GmbH · completed · Iron Deficiency Anemia · study director
- Ph3NCT01408576 · Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusUCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph2NCT01407523 · An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset SeizuresUCB Japan Co. Ltd. · completed · Epilepsy, Partial Onset Seizures · study director
- Ph3NCT01405508 · Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic TherapyUCB Pharma · completed · Epilepsy · study director
- Ph3NCT01398956 · An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic SeizuresUCB Pharma · completed · Epilepsy, Generalized Tonic-clonic Seizures · study director
- Ph1NCT01394224 · Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese SubjectsUCB Pharma · completed · Healthy Volunteers · study director
- N/ANCT01386944 · Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced AugmentationUCB Pharma · completed · Restless Legs Syndrome · study director
- Ph1NCT01375387 · Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese MalesUCB Pharma · completed · Healthy Volunteers · study director
- Ph1NCT01338896 · Study to Compare Adhesiveness of Two Different Rotigotine Patch FormulationsUCB Pharma · completed · Parkinson's Disease · study director
- N/ANCT01330290 · Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver SupportUCB Pharma · completed · Idiopathic Parkinson's Disease · study director
- Ph4NCT01300819 · Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor SymptomsUCB Pharma · completed · Idiopathic Parkinson's Disease · study director
- Ph3NCT01292837 · A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic SeizuresUCB Japan Co. Ltd. · completed · Epilepsy, Generalized Tonic-clonic Seizures · study director
- Ph3NCT01292265 · A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)UCB Pharma · terminated · Rheumatoid Arthritis · study director
- N/ANCT01288287 · Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) PatientsUCB Pharma · completed · Arthritis,Rheumatoid · study director
- Ph1NCT01276119 · The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy MalesUCB Pharma · completed · Pharmacokinetics · study director
- Ph3NCT01263925 · Prostaglandin E1 in Outpatients With Intermittent ClaudicationUCB Pharma · completed · Stage II Peripheral Arterial Occlusive Disease, Intermittent Claudication Fontaine Stage II PAOD · study director
- Ph1NCT01262794 · Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male SubjectsUCB Pharma · completed · Healthy Volunteers · study director
- Ph3NCT01262365 · Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus ErythematosusUCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph3NCT01261793 · Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)UCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph3NCT01261325 · Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph4NCT01255761 · A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph2NCT01242488 · Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyUCB Pharma · completed · Rheumatoid Arthritis · study director
- N/ANCT01236001 · Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and OlderUCB Pharma · completed · Seizures · study director
- Ph4NCT01235403 · Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset SeizureUCB Pharma · completed · Partial Epilepsies · study director
- Ph3NCT01235598 · Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)UCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph4NCT01229735 · Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset SeizuresUCB Korea Co., Ltd. · completed · Epilepsy · study director
- Ph3NCT01228747 · A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)UCB Japan Co. Ltd. · completed · Epilepsy, Generalized Tonic-Clonic Seizures · study director
- N/ANCT01210690 · Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral SolutionUCB Pharma · completed · Epilepsy · study director
- Ph2NCT01190410 · Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab PegolUCB Pharma · completed · Crohn's Disease · study director
- N/ANCT01159691 · Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal PatchUCB Pharma GmbH · completed · Idiopathic Parkinson's Disease · study director
- Ph2NCT01118962 · Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyUCB BIOSCIENCES, Inc. · completed · Epilepsy · study director
- Ph2NCT01118949 · Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyUCB BIOSCIENCES, Inc. · completed · Epilepsy · study director
- N/ANCT01113710 · Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily PractiseUCB Pharma · completed · Idiopathic Restless Legs Syndrome · study director
- N/ANCT01098162 · Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic DrugUCB Pharma GmbH · completed · Epilepsies, Partial · study director
- N/ANCT01095484 · Named Patient Program With Rotigotine Transdermal SystemUCB Pharma · completed · Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine · study director
- Ph1NCT01093911 · Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)UCB Pharma · completed · Immune System Diseases, Autoimmune Diseases, Lupus Erythematosus, Systemic · study director
- Ph1NCT01091220 · Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male VolunteersUCB Pharma · completed · Sperm Quality · study director
- Ph3NCT01087762 · Certolizumab Pegol in Subjects With Active Axial SpondyloarthritisUCB BIOSCIENCES GmbH · completed · Spondyloarthropathies · study director
- Ph3NCT01087788 · Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisUCB BIOSCIENCES GmbH · completed · Arthritis, Psoriatic · study director
- N/ANCT01069419 · Observation of Treatment With Certolizumab Pegol in Daily PracticeUCB Pharma GmbH · completed · Rheumatoid Arthritis · study director
- Ph3NCT01063764 · An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial SeizuresUCB Japan Co. Ltd. · completed · Epilepsy, Partial Seizures · study director
- Ph1NCT01059903 · Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the BodyUCB Pharma · completed · Healthy Volunteers · study director
- Ph1/Ph2NCT01009242 · To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using MethotrexateUCB Pharma · completed · Arthritis, Rheumatoid Arthritis · study director
- Ph4NCT00993668 · Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph1NCT00985348 · Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)UCB Pharma · completed · Healthy · study director
- Ph2NCT00961441 · Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With EpilepsyUCB BIOSCIENCES, Inc. · completed · Epilepsy · study director
- Ph1NCT00957944 · Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the BodyUCB Pharma · completed · Healthy Volunteers · study director
- Ph4NCT00955357 · Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset SeizuresUCB Pharma · completed · Partial Epilepsies · study director
- Ph2NCT00938431 · A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph2NCT00899678 · The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and AdolescentsUCB Celltech · terminated · Crohn's Disease · study director
- Ph1NCT00881894 · Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.UCB Pharma · completed · Healthy · study director
- Ph2NCT00861445 · A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic NeuropathyUCB Pharma · completed · Painful Diabetic Neuropathy · study director
- Ph2NCT00861068 · A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).UCB Pharma · completed · Postherpetic Neuralgia · study director
- Ph2NCT00861042 · An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic NeuropathyUCB Pharma · completed · Painful Diabetic Neuropathy · study director
- Ph1NCT00845663 · Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)UCB Pharma · completed · Healthy · study director
- Ph3NCT00843778 · Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph1NCT00813774 · Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy VolunteersUCB Pharma · completed · Bioavailability Study on Healthy Volunteers · study director
- Ph2NCT00800215 · A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927UCB Pharma · completed · Epilepsy · study director
- N/ANCT00771927 · Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset SeizuresUCB Pharma · completed · Epilepsies, Partial · study director
- Ph3NCT00753454 · Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)UCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph1NCT00736931 · Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: BrivaracetamUCB Pharma · completed · Epilepsy · study director
- Ph1/Ph2NCT00726648 · CDP323 Biomarker StudyUCB Pharma · completed · Relapsing Multiple Sclerosis · study director
- Ph3NCT00717236 · Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid ArthritisUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph3NCT00698581 · A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresUCB Pharma · terminated · Epilepsy · study director
- Ph3NCT00699283 · A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresUCB Pharma · terminated · Epilepsy · study director
- Ph3NCT00674362 · Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph2NCT00660881 · Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active DiseaseUCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph3NCT00655486 · Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset SeizuresUCB BIOSCIENCES, Inc. · completed · Partial Epilepsies, Partial Onset Seizures · study director
- Ph3NCT00655551 · Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresUCB BIOSCIENCES, Inc. · completed · Partial Epilepsies, Partial Onset Seizures · study director
- Ph4NCT00653224 · A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisUCB Pharma · completed · Seasonal Allergic Rhinitis · study director
- Ph4NCT00643500 · Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in EpilepsyUCB Pharma · completed · Epilepsy, Partial · study director
- Ph3NCT00639587 · Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic RhinitisUCB Pharma · completed · Rhinitis, Allergic, Perennial · study director
- Ph4NCT00630968 · S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in EpilepsyUCB Pharma · completed · Epilepsy · study director
- Ph4NCT00631150 · A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in EpilepsyUCB Pharma · completed · Epilepsy · study director
- Ph4NCT00630357 · Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial EpilepsyUCB Pharma · completed · Epilepsy · study director
- Ph4NCT00630630 · Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial EpilepsyUCB Pharma · completed · Epilepsy · study director
- Ph3NCT00628108 · Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 MonthsUCB Pharma · completed · Allergic Rhinitis, Chronic Urticaria · study director
- Ph2NCT00624351 · Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active DiseaseUCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph4NCT00621959 · A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisUCB Pharma · completed · Seasonal Allergic Rhinitis · study director
- Ph3NCT00619801 · Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown OriginUCB Pharma · completed · Allergic Rhinitis, Chronic Urticaria · study director
- Ph3NCT00619229 · Alprostadil in Maculopathy Study (AIMS)UCB Pharma · terminated · Macular Degeneration · study director
- N/ANCT00614549 · Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.UCB Pharma · completed · Epilepsy · study director
- Ph2NCT00612859 · Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)UCB Pharma · completed · Anxiety Disorders · study director
- Ph2NCT00610454 · Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph2NCT00600509 · Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind MethodUCB Pharma · completed · Epilepsy · study director
- N/ANCT00598780 · Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional StudyUCB Pharma · completed · Rhinitis Allergic, Persistent · study director
- N/ANCT00599339 · Transdermal Rotigotine User Surveillance StudyUCB Pharma · completed · Idiopathic Parkinson Disease · study director
- Ph3NCT00599196 · An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's DiseaseUCB Pharma · completed · Early Stage Parkinson's Disease · study director
- Ph4NCT00596752 · Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IVUCB BIOSCIENCES GmbH · completed · Peripheral Arterial Occlusive Disease · study director
- Ph3NCT00594386 · An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's DiseaseUCB Pharma · completed · Parkinson's Disease · study director
- Ph3NCT00593606 · Safety and Tolerability Trial of Switching From Ropinirole to RotigotineUCB Pharma · completed · Parkinson's Disease · study director
- Ph4NCT00594464 · A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing SurgeryUCB Pharma · completed · Parkinson's Disease · study director
- Ph3NCT00594165 · An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.UCB Pharma · completed · Early-Stage Parkinson's Disease · study director
- Ph4NCT00580840 · Dosing Flexibility Study in Patients With Rheumatoid ArthritisUCB Pharma · completed · Rheumatoid Arthritis · study director
- N/ANCT00567060 · Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)UCB Pharma · completed · Memory Disorders · study director
- Ph3NCT00552344 · A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's DiseaseUCB BIOSCIENCES GmbH · completed · Crohn Disease · study director
- Ph2NCT00552305 · To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresUCB Pharma · completed · Partial Epilepsies · study director
- Ph3NCT00552058 · Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's DiseaseUCB Pharma · completed · Crohn Disease · study director
- Ph3NCT00548834 · Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisUCB Pharma · completed · Rheumatoid Arthritis · study director
- Ph3NCT00546351 · Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.UCB Pharma · completed · Painful Diabetic Neuropathy · study director
- Ph3NCT00544388 · Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive SubjectsUCB Pharma · completed · Rhinitis, Allergic, Seasonal · study director
- Ph3NCT00544154 · Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid ArthritisUCB Pharma · completed · Arthritis, Rheumatoid · study director
- Ph2NCT00545012 · A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence SeizuresUCB Pharma · completed · Absence Seizures · study director
- Ph2NCT00544050 · Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years OldUCB Pharma · completed · Epilepsy · study director
- Ph4NCT00542607 · Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic RhinitisUCB Pharma · completed · Rhinitis, Allergic, Seasonal · study director
- Ph2NCT00535392 · Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With EpilepsyUCB Pharma · completed · Epilepsy · study director
- Ph3NCT00530855 · Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph3NCT00525382 · Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic UrticariaUCB Pharma · completed · Urticaria · study director
- Ph3NCT00524836 · Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic RhinitisUCB Pharma · completed · Rhinitis, Allergic, Perennial · study director
- Ph3NCT00525278 · To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic RhinitisUCB Pharma · completed · Rhinitis, Allergic, Seasonal · study director
- N/ANCT00522522 · Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of EpilepsyUCB Pharma · completed · Epilepsy · study director
- Ph3NCT00522275 · Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresUCB BIOSCIENCES, Inc. · completed · Partial Epilepsies · study director
- Ph3NCT00522379 · Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal PatchUCB Pharma · completed · Parkinson's Disease · study director
- Ph4NCT00521131 · Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust MitesUCB Pharma · completed · Rhinitis, Allergic, Perennial · study director
- Ph3NCT00520741 · Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset SeizuresUCB BIOSCIENCES, Inc. · completed · Epilepsy · study director
- Ph2NCT00520754 · Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in ChildrenUCB Pharma · completed · Cough · study director
- Ph1NCT00521170 · Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.UCB Pharma · completed · Allergy · study director
- N/ANCT00521040 · Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARUCB Pharma · completed · Rhinitis, Allergic, Seasonal · study director
- Ph3NCT00519532 · Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseUCB Pharma · terminated · Parkinson's Disease · study director
- Ph3NCT00515619 · Assess Safety and Efficacy of Lacosamide in Patients With Partial SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph2NCT00505934 · Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With EpilepsyUCB Pharma SA · completed · Epilepsy · study director
- Ph3NCT00505687 · An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseUCB Pharma · completed · Idiopathic Parkinson's Disease · study director
- Ph3NCT00504881 · Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From EpilepsyUCB Pharma SA · completed · Epilepsy · study director
- Ph3NCT00501969 · An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's DiseaseUCB Pharma · completed · Advanced Stage Parkinson's Disease · study director
- Ph2NCT00498186 · Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)UCB Pharma · completed · Restless Legs Syndrome · study director
- Ph3NCT00498108 · Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome SubjectsUCB Pharma · completed · Idiopathic Restless Legs Syndrome · study director
- Ph3NCT00490035 · Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresUCB Pharma SA · completed · Epilepsy · study director
- Ph2NCT00485472 · Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the KneeUCB Pharma · terminated · Osteoarthritis · study director
- Ph2NCT00484536 · Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323UCB Pharma · terminated · Multiple Sclerosis · study director
- Ph3NCT00474058 · Randomized Evaluation of the 24-Hour Coverage: Efficacy of RotigotineUCB Pharma · completed · Parkinson's Disease · study director
- Ph2NCT00464737 · The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.UCB Pharma · completed · Fibromyalgia Syndrome · study director
- Ph3NCT00464269 · Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresUCB Pharma · completed · Epilepsy · study director
- N/ANCT00453583 · Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an AntihistamineUCB Pharma · completed · Allergies · study director
- Ph2NCT00440518 · A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine ProphylaxisUCB Pharma · completed · Migraine · study director
- Ph2NCT00422422 · Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.UCB Pharma · completed · Epilepsy · study director
- Ph3NCT00419393 · Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph3NCT00419094 · Conversion to Monotherapy Study With Keppra XR for Partial SeizuresUCB Pharma · completed · Epilepsy · study director
- Ph2NCT00401830 · Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.UCB Pharma · completed · Fibromyalgia Syndrome · study director
- Ph2NCT00383513 · Study of Epratuzumab in Systemic Lupus ErythematosusUCB Pharma · completed · Systemic Lupus Erythematosus · study director
- Ph3NCT00368069 · A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XRUCB Pharma · completed · Epilepsy · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.